62 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
at a future date, which is a derivative liability accounted for at FVTPL.
The obligation to pay royalties of $16 million USD is classified as a financial
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
The obligation to pay royalties of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently … were classified as liability. Management was required to make estimates to determine the fair value of the components of the preference share
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
at an agreed price at a future date, which is a derivative liability accounted for at FVTPL.
The obligation to pay royalties of $16 million USD is classified
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently at amortized cost. Management … redemption RepliCel preference shares were classified as liability. Management was required to make estimates to determine the fair value of the components
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
for at FVTPL.
- 12 -
The obligation to pay royalties of $16 million USD is classified as a financial liability and measured initially at its fair value … to required redemption RepliCel preference shares were classified as liability. Management was required to make estimates to determine the fair value
6-K
EX-99.1
g1ep3pw
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.2
8t9zpy3pa5as kjosb
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
9j8fnungexd21gd
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
bz68z 58sc
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
vvbr1rkk2s
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
dio9m7s
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.3
2hjyvjbqouoxx6 0rnr7
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
ckzwsh4alx
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
mmgv2k5pn4x63
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
lillcd4y
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
mp4yulr7
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
4y55i0tp 3vtt0m4dck
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
vh4 jsdyfwa
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm